Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease

NCT01123369 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT01123369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01123369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease
Lead sponsor
Medical University of South Carolina
Phase
Observational
Overall status
Completed
Start date
February 28, 2010
Completion date
July 31, 2010
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease